Innovative therapies are significantly shifting the paradigm of metabolic disease . BPC-157 , along with several substances , showcase potential possibilities in treating conditions like type second glucose intolerance and obesity . While investigations are continuing, early results suggest impressive gains in glucose control and body reduction ,